Moderna revealed its combination flu/COVID vaccine performed better than the two shots independently.
) is on its way to getting a third mRNA-based vaccine approved by the FDA if the regulatory agency likes the data released Monday for a combination flu- COVID shot.
The biotech firm has enjoyed the spotlight as its brand-new platform became a frontrunner, and ultimately one of the two key vaccines, in addressing the pandemic. Since the multibillion-dollar COVID windfall, investors have been anxious about the near-term prospects of Moderna.
Hoge said it will take a reasonable outlook, but notes the company is already up to three vaccines in two years and has late-stage trial data expected for three more in the near term. But it's also important to note that Moderna's current pipeline is mainly respiratory vaccines, which will not provide the type of profits to make up for the loss in the COVID portfolio.
Still, he noted that much of the company's investment is now in clinical trials, and he expects the newer products to add to the company's revenues sooner rather than later.
Canada Latest News, Canada Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Moderna wins patent case in Europe against Pfizer, BioNTech over COVID shotPfizer said it was disappointed and would consider all legal options and may appeal the decision
Read more »
Moderna wins COVID shot patent case against Pfizer-BioNTech in EuropeModerna has been locked in a legal battle with Pfizer-BioNTech over their COVID shot Comirnaty after suing them in 2022 for allegedly copying its mRNA technology
Read more »
Moderna’s Flu, Covid Combo Shot Meets Goal in Late-Stage TrialModerna Inc. said its combination flu and Covid shot met the goals of a pivotal late-stage trial, bringing the company one step closer to a more convenient jab that could help combat vaccine fatigue.
Read more »
COVID-flu shot offers strong immune response in late-stage trial, Moderna saysModerna says it combination vaccine to protect against both COVID-19 and influenza generated a stronger immune response in adults 50 and over when compared to separate shots.
Read more »
US nears deal to fund Moderna's bird flu vaccine trial, FT reportsExplore stories from Atlantic Canada.
Read more »
US nears deal to fund Moderna's bird flu vaccine trial, FT reportsExplore stories from Atlantic Canada.
Read more »